recombinant mouse ccl2 (R&D Systems)
95
Structured Review
R&D Systems
recombinant mouse ccl2
![Intratracheal administration of 0.5μg TNF (A and B) or 50μg poly(I:C) (C and D) to A20 AEC-KO or wild type littermates (A20 WT ). Absolute numbers of neutrophils or monocytes in bronchoalveolar lavages (BAL) as determined by flow cytometry at 6h and 24h post-treatment for TNF (A) or 24h post-treatment for poly(I:C) (C). IL-6, CXCL1 (KC), <t>CCL2</t> (MCP-1) and TNF [only for poly(I:C)] protein levels in BAL fluid detected by Multiplex immunoassay (B and D). Data represent mean ± SEM of at least 4 mice per group (*p < 0.05; Student’s t -test).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1390/pmc04731390/pmc04731390__ppat.1005410.g001.jpg)
Recombinant Mouse Ccl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 166 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+protein+array+system+technology/Recombinant+Mouse+CCL2%2FJE%2FMCP-1+Protein/pmc04731390-147-0-3
Average 95 stars, based on 166 article reviews
![Intratracheal administration of 0.5μg TNF (A and B) or 50μg poly(I:C) (C and D) to A20 AEC-KO or wild type littermates (A20 WT ). Absolute numbers of neutrophils or monocytes in bronchoalveolar lavages (BAL) as determined by flow cytometry at 6h and 24h post-treatment for TNF (A) or 24h post-treatment for poly(I:C) (C). IL-6, CXCL1 (KC), <t>CCL2</t> (MCP-1) and TNF [only for poly(I:C)] protein levels in BAL fluid detected by Multiplex immunoassay (B and D). Data represent mean ± SEM of at least 4 mice per group (*p < 0.05; Student’s t -test).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1390/pmc04731390/pmc04731390__ppat.1005410.g001.jpg)
Recombinant Mouse Ccl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 166 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+protein+array+system+technology/Recombinant+Mouse+CCL2%2FJE%2FMCP-1+Protein/pmc04731390-147-0-3
Average 95 stars, based on 166 article reviews
recombinant mouse ccl2 - by Bioz Stars,
2026-11
95/100 stars
Images
1) Product Images from "A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection"
Article Title: A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection
Journal: PLoS Pathogens
doi: 10.1371/journal.ppat.1005410
Figure Legend Snippet: Intratracheal administration of 0.5μg TNF (A and B) or 50μg poly(I:C) (C and D) to A20 AEC-KO or wild type littermates (A20 WT ). Absolute numbers of neutrophils or monocytes in bronchoalveolar lavages (BAL) as determined by flow cytometry at 6h and 24h post-treatment for TNF (A) or 24h post-treatment for poly(I:C) (C). IL-6, CXCL1 (KC), CCL2 (MCP-1) and TNF [only for poly(I:C)] protein levels in BAL fluid detected by Multiplex immunoassay (B and D). Data represent mean ± SEM of at least 4 mice per group (*p < 0.05; Student’s t -test).
Techniques Used: Flow Cytometry, Multiplex Assay
Figure Legend Snippet: (A) Absolute numbers of monocytes, neutrophils and alveolar macrophages in bronchoalveolar lavages (BAL) of A20 AEC-KO or A20 WT mice at 2, 5, 8 and 12 days post-infection (days p.i.) with 0.05 X LD 50 X-47. (B) Absolute numbers of resident CD11b - or recruited CD11b + macrophages in the lungs of A20 WT and A20 AEC-KO mice. (C) CCL2 (MCP-1) protein levels in BAL fluid measured by Multiplex immunoassay at indicated time points post-infection. (D) Weight loss of A20 AEC-KO and A20 WT mice infected with 0.05 X LD 50 X-47. At day 6 p.i. (indicated by an arrow) mice received intranasal treatment with 50 μg/kg recombinant CCL2 (rCCL2) or PBS. Data were analysed using Student’s t -test (A, B and C *p < 0.05) and 2-way ANOVA (D, *p < 0.05 for A20 AEC-KO PBS vs. A20 WT PBS and # p < 0.05 for A20 AEC-KO PBS vs A20 AEC-Cre rCCL2). Data represent mean ± SEM of at least 3 mice per group. Data are representative of at least 2 independent experiments.
Techniques Used: Infection, Multiplex Assay, Recombinant
Related Articles
Incubation:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( Recombinant:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( Mouse Assay:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( Injection:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( RNAscope:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( Isolation:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( Multiplex Assay:Article Title: CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis. Article Snippet: : 60.7% DMEM (GIBCO 11965-092, Thermo Fisher Scientific), 30.3% F-12 (GIBCO 11765-054, Thermo Fisher Scientific), 2% B-27 supplement (GIBCO 17504-044, Thermo Fisher Scientific), 7% PBS, 10 ng/mL CCL2 ( |